CABERGOLINE - AN ADVANCE IN DOPAMINERGIC THERAPY

被引:13
作者
BEVAN, JS [1 ]
DAVIS, JRE [1 ]
机构
[1] MANCHESTER ROYAL INFIRM,DEPT ENDOCRINOL,MANCHESTER M13 9WL,LANCS,ENGLAND
关键词
D O I
10.1111/j.1365-2265.1994.tb02782.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:709 / 712
页数:4
相关论文
共 29 条
  • [11] LONG-LASTING LOWERING OF SERUM GROWTH-HORMONE AND PROLACTIN LEVELS BY SINGLE AND REPETITIVE CABERGOLINE ADMINISTRATION IN DOPAMINE-RESPONSIVE ACROMEGALIC PATIENTS
    FERRARI, C
    PARACCHI, A
    ROMANO, C
    GEREVINI, G
    BOGHEN, M
    BARRECA, A
    FORTINI, P
    DUBINI, A
    [J]. CLINICAL ENDOCRINOLOGY, 1988, 29 (05) : 467 - 476
  • [12] FRANS E, 1992, EUR RESPIR J, V5, P263
  • [13] A DOUBLE-BLIND-STUDY COMPARING A NEW NONERGOT, LONG-ACTING DOPAMINE AGONIST, CV 205-502, WITH BROMOCRIPTINE IN WOMEN WITH HYPERPROLACTINEMIA
    HOMBURG, R
    WEST, C
    BROWNELL, J
    JACOBS, HS
    [J]. CLINICAL ENDOCRINOLOGY, 1990, 32 (05) : 565 - 571
  • [14] PROLACTIN-LOWERING EFFECT OF ACUTE AND ONCE WEEKLY REPETITIVE ORAL-ADMINISTRATION OF CABERGOLINE AT 2 DOSE LEVELS IN HYPERPROLACTINEMIC PATIENTS
    MATTEI, AM
    FERRARI, C
    BAROLDI, P
    CAVIONI, V
    PARACCHI, A
    GALPAROLI, C
    ROMANO, C
    SPELLECCHIA, D
    GEREVINI, G
    CROSIGNANI, PG
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1988, 66 (01) : 193 - 198
  • [15] MELIS GB, 1989, FERTIL STERIL, V52, P412
  • [16] TWICE WEEKLY CABERGOLINE TREATMENT OF MACROPROLACTINOMA
    MOTTA, T
    MAGGI, G
    DALBERTON, A
    FERRARI, C
    PARACCHI, A
    [J]. JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 1989, 9 (04) : 334 - 335
  • [17] CABERGOLINE THERAPY OF A LARGE PROLACTINOMA IN A BROMOCRIPTINE-INTOLERANT PATIENT
    PAGE, SR
    NUSSEY, SS
    [J]. JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 1989, 10 (02) : 156 - 158
  • [18] RESISTANCE TO BROMOCRIPTINE IN PROLACTINOMAS
    PELLEGRINI, I
    RASOLONJANAHARY, R
    GUNZ, G
    BERTRAND, P
    DELIVET, S
    JEDYNAK, CP
    KORDON, C
    PEILLON, F
    JAQUET, P
    ENJALBERT, A
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1989, 69 (03) : 500 - 509
  • [19] INHIBITION OF BASAL AND METOCLOPRAMIDE-INDUCED PROLACTIN-RELEASE BY CABERGOLINE, AN EXTREMELY LONG-ACTING DOPAMINERGIC DRUG
    PONTIROLI, AE
    CAMMELLI, L
    BAROLDI, P
    POZZA, G
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1987, 65 (05) : 1057 - 1059
  • [20] LONG-TERM TREATMENT OF GALACTORRHEA AND HYPOGONADISM WITH BROMOCRIPTINE
    THORNER, MO
    MCNEILLY, AS
    HAGAN, C
    BESSER, GM
    [J]. BRITISH MEDICAL JOURNAL, 1974, 2 (5916) : 419 - 422